Latest stories on BLSM
BlossomHill Therapeutics: A Deliberate Beachhead Trading Back At Its IPO Price
Seeking Alpha63 · neutralanalyst
BlossomHill Therapeutics enters CDx collaboration with Foundation Medicine
The Fly61 · neutralproduct/pr
H.C. Wainwright reiterates Buy on BlossomHill stock, $35 target
Investing.com Analyst Ratings61 · neutralanalyst
BlossomHill Therapeutics presents preclinical data on BH-501284 at AACR
The Fly63 · neutralproduct/pr
BlossomHill Therapeutics Presents Preclinical Data on Novel Pan-KRAS Inhibitor, BH-501284, at the AACR Conference on Pancreatic Cancer
GlobeNewswire67 · bullishproduct/pr
BlossomHill Therapeutics Presents Preclinical Data on Novel Pan-KRAS Inhibitor, BH-501284, at the AACR Conference on Pancreatic Cancer
Business Insider67 · bullishproduct/pr
BlossomHill Therapeutics price target raised to $40 from $36 at Leerink
The Fly61 · neutralanalyst
Guggenheim raises BlossomHill Therapeutics price target to $40 on pipeline progress
Investing.com Analyst Ratings61 · neutralanalyst
BlossomHill Therapeutics price target raised to $40 from $30 at Guggenheim
The Fly65 · bullishanalyst
BlossomHill Therapeutics, Inc. (BLSM) files 8-K
SEC 8-K50 · neutralgeneral
BlossomHill Therapeutics Reports Second Quarter 2026 Financial Results
GlobeNewswire24 · bearishgeneral
BlossomHill Therapeutics Reports Second Quarter 2026 Financial Results
Business Insider24 · bearishgeneral
BlossomHill closes up 18% on strongest day since August IPO
Seeking Alpha73 · bullishearnings
BlossomHill Therapeutics Shares Rise 4.4% After BH-30643 Trial Update
Yahoo Top63 · neutralproduct/pr
BlossomHill Therapeutics Shares Rise 4.4% After BH-30643 Trial Update
InvestorsHub63 · neutralproduct/pr
Why is BlossomHill Therapeutics stock rallying today?
Investing.com Markets50 · neutralgeneral
BlossomHill Therapeutics, Inc. (BLSM) files 8-K
SEC 8-K50 · neutralgeneral
BlossomHill Therapeutics to Present at the 8th Annual RAS-Targeted Drug Development Summit & H.C. Wainwright 28th Annual Global Investment Conference
Business Insider56 · neutralproduct/pr
BlossomHill Therapeutics initiated with an Outperform at Leerink
The Fly61 · neutralanalyst
Guggenheim starts BlossomHill Therapeutics with a Buy on pipeline potential
The Fly61 · neutralanalyst